Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

OBJECTIVES: Whether the duration of maintenance treatment with azathioprine (AZA) affects the outcome of ulcerative colitis (UC) is unclear. We investigated clinical outcomes and any predictive factors after withdrawal of AZA in UC. METHODS: In this multicenter observational retrospective study, 12...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassinotti, A, Actis, G, Duca, P, Massari, A, Colombo, E, Gai, E, Annese, V, D'Albasio, G, Manes, G, Travis, S, Porro, G, Ardizzone, S
Formato:	Journal article
Lenguaje:	English
Publicado:	2009

Ejemplares similares

Azathioprine in ulcerative colitis.
por: Jewell, D, et al.
Publicado: (1972)

IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool.
por: Cassinotti, A, et al.
Publicado: (2009)

Azathioprine-Induced Pericarditis in a Patient with Ulcerative Colitis
por: C David Simpson
Publicado: (1997-01-01)

Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
por: Kyrillus S Shohdy, et al.
Publicado: (2018-01-01)

Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.
por: Jewell, D, et al.
Publicado: (1974)

Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial.
por: Jewell, D, et al.
Publicado: (1972)

Review: Immunomodulators for all patients with inflammatory bowel disease?
por: Sandro Ardizzone, et al.
Publicado: (2010-01-01)

Evaluation of low doses of Azathioprine in reducing relapse and corticosteroid dependence in patients with Ulcerative Colitis
por: Maryam Rezaiee, et al.
Publicado: (2019-05-01)

Modified Kudo classification can improve accuracy of virtual chromoendoscopy with FICE in endoscopic surveillance of ulcerative colitis
por: Andrea Cassinotti, et al.
Publicado: (2020-09-01)

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial
por: Marianne Kiszka-Kanowitz, et al.
Publicado: (2022-03-01)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
por: Tong Li, et al.
Publicado: (2020-11-01)

6-Mercaptopurine Or Azathioprine?
por: McGovern, D, et al.
Publicado: (2007)

Biologics for Ulcerative Colitis: Status of the Art and General Considerations
por: Giovanni Clemente Actis
Publicado: (2017-03-01)

Infliximab and azathioprine: bridge or parachute?
por: Travis, S
Publicado: (2006)

Granulocyte-Monocyte Apheresis in Steroid-Dependent, Azathioprine-Intolerant/Resistant Moderate Ulcerative Colitis: A Prospective Multicenter Study
por: Gianni Imperiali, et al.
Publicado: (2017-01-01)

A rare case report: Myopathy related to the interaction between azathioprine and infliximab in the treatment of ulcerative colitis and ankylosing spondylitis
por: Lingyu Fu, et al.
Publicado: (2024-06-01)

Adalimumab for the treatment of Crohn&rsquo;s disease
por: Andrea Cassinotti, et al.
Publicado: (2008-09-01)

Intensification of maintenance therapy with infliximab in ulcerative colitis
por: Francesc Casellas

Infliximab treatment in a paediatric patient with ulcerative colitis, who developed acute pancreatitis due to azathioprine during follow-up
por: Ahmet Basturk, et al.
Publicado: (2017-09-01)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
por: Maconi G, et al.
Publicado: (2021-04-01)

The European consensus on ulcerative colitis: new horizons?
por: Stange, E, et al.
Publicado: (2008)

Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.
por: Campbell, A, et al.
Publicado: (1976)

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
por: Jairath, V, et al.
Publicado: (2017)

Review article: maintenance therapy in patients with ulcerative colitis.
por: Orchard, T, et al.
Publicado: (2006)

Predicting outcome in severe ulcerative colitis.
por: Travis, S
Publicado: (2004)

Ulcerative colitis and sarcoidosis.
por: Barr, G, et al.
Publicado: (1986)

Insights into the role of gastrointestinal ultrasound in ulcerative colitis
por: Cristina Bezzio, et al.
Publicado: (2021-10-01)

Salicylates for ulcerative colitis--their mode of action.
por: Travis, S, et al.
Publicado: (1994)

Therapy of ulcerative colitis: state of the art.
por: Brain, O, et al.
Publicado: (2008)

Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission
por: Rubin, D, et al.
Publicado: (2019)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
por: An-Yu Chen, et al.
Publicado: (2019-09-01)

Therapeutic landscape for ulcerative colitis: where is the Adacolumn&reg; system and where should it be?
por: D&rsquo;Inc&agrave; R, et al.
Publicado: (2013-01-01)

MESALAZINE PLACE IN THERAPY OF ULCERATIVE COLITIS
por: I. G. Bakulin, et al.
Publicado: (2017-11-01)

Expression of lectins in nonspecific ulcerative colitis
por: Maslyakova G.N., et al.
Publicado: (2012-12-01)

Comparing disease activity indices in ulcerative colitis
por: Walsh, A, et al.
Publicado: (2014)

Comparing disease activity indices in ulcerative colitis.
por: Walsh, A, et al.
Publicado: (2014)

Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
por: Travis, S, et al.
Publicado: (1994)

Azathioprine and Steroids
por: Knight, SR, et al.
Publicado: (2008)

Oral methotrexate in ulcerative colitis.
por: Cummings, JR, et al.
Publicado: (2005)

Assessing disease activity in patients with ulcerative colitis.
por: Walsh, A, et al.
Publicado: (2012)